Should butalbital-containing analgesics be banned? Yes.
- William B. YoungAffiliated withJefferson Headache Center, Department of Neurology, Thomas Jefferson University
- , Hua Chiang SiowAffiliated withJefferson Headache Center, Department of Neurology, Thomas Jefferson University
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
In the United States analgesic-overuse headache is often caused by butalbital-containing analgesics. These agents can cause physical and psychological dependency, and dangerous withdrawal syndromes. Butalbital-containing analgesics have already been banned in several European countries. They are proven effective in tension-type headache, but not in migraine; there are many alternative treatments for migraine and tension-type headache. In the 20 years since analgesic overuse headache was widely recognized, butalbital overuse has remained distressingly common. It is time to ban these agents.
- Should butalbital-containing analgesics be banned? Yes.
Current Pain and Headache Reports
Volume 6, Issue 2 , pp 151-155
- Cover Date
- Print ISSN
- Online ISSN
- Current Medicine Group
- Additional Links